Company Filing History:
1 out of 1 
1 out of 1,271 
1 out of 44 
Years Active: 2010
Title: Maria Graziewicz: Innovator in TNF Antagonist Research
Introduction
Maria Graziewicz is a notable inventor based in Chapel Hill, NC (US). She has made significant contributions to the field of biomedical research, particularly in the development of tumor necrosis factor (TNF) antagonists. Her work focuses on innovative solutions for treating inflammatory diseases.
Latest Patents
Maria Graziewicz holds a patent for "Soluble TNF receptors and their use in treatment of disease." This invention relates to TNF antagonists and corresponding nucleic acids derived from tumor necrosis factor receptors (TNFRs). The soluble secreted decoy receptors bind to TNF, preventing it from signaling to cells. Specifically, these proteins are mammalian TNFRs that lack exon 7, allowing them to bind TNF and act as antagonists.
Career Highlights
Throughout her career, Maria has worked with prominent organizations such as Ercole Biotech, Inc. and the University of North Carolina at Chapel Hill. Her research has been pivotal in advancing the understanding and treatment of inflammatory diseases.
Collaborations
Maria has collaborated with esteemed colleagues, including Peter L. Sazani and Ryszard M. Kole. Their joint efforts have contributed to the success of her research and innovations in the field.
Conclusion
Maria Graziewicz is a pioneering inventor whose work on TNF antagonists has the potential to transform the treatment of inflammatory diseases. Her contributions to biomedical research continue to inspire advancements in healthcare.